Trethera
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
13547 Ventura Blvd Pmb 363, Sherman Oaks...Phone Number
(310) 997-2788Website
www.trethera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Trethera
Trethera is a biotechnology company focused on developing innovative therapies for cancer, autoimmune, and neuroinflammatory diseases, with its lead product being TRE-515, a first-in-class dCK inhibitor. The company leverages extensive research and development expertise to create transformative treatments that aim to provide safer and more effective solutions for patients facing limited options. Trethera is currently advancing its pipeline through clinical trials, emphasizing a patient-centered approach and rigorous scientific methods. With a commitment to pioneering drug breakthroughs, Trethera is dedicated to changing the landscape of treatment for complex diseases.Explore more
Trethera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trethera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Trethera is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Trethera launches new products
Earning: See what the market has to say on Trethera recently announced quarterly report
Check if Trethera has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Trethera has new funding data
Congratulate Masked Content for being promoted to Masked Content at Trethera
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Trethera had a recent Job posting/layoffs
Trethera, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Trethera
Compare insights from companies similar to Trethera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Trethera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trethera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trethera.
Trethera Tech Stack
A closer look at the technologies used by Trethera
See more technologies
Trethera News & Media
Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors
Drew Woodmansee Board Appointment strengthens Trethera with deep patent expertise and capital formation experience, supporting its next phase of growth.Trethera Announces Massachusetts General Hospital Clinical Trial Collaboration to Evaluate TRE-515 in ALS Patients
MGH collaboration to evaluate TRE-515 in ALS patients, advancing development of a first-in-class therapy targeting inflammation and nucleotide metabolism.Trethera to Highlight Clinical Momentum and Indication Expansion at Biocom Global Partnering & Investor Conference
Presentation highlights Phase 1 trial completion, FDA Fast Track and Orphan Drug designations, and the expanding pipeline-in-a-product potential of TRE-515Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer
$2.7M NIH grant evaluates TRE-515 with KRAS inhibitors in lung cancer, boosting Trethera’s FDA Fast Track pipeline with a novel approach to resistance
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trethera
Sign Up For FreeTo access detailed company insights
Trethera is a biotechnology company focused on developing innovative therapies for cancer, autoimmune, and neuroinflammatory diseases, with its lead product being TRE-515, a first-in-class dCK inhibitor. The company leverages extensive research and development expertise to create transformative treatments that aim to provide safer and more effectiv... Read More
